Prab at 20:23, 24 June 2026

2026-06-24T20:23:09Z

← Older revision		Revision as of 20:23, 24 June 2026
Line 12:		Line 12:
	\| related = [[Semaglutide]], [[Wegovy]], [[Ozempic]], [[Liraglutide]], [[Saxenda]], [[GLP-1 receptor agonist]], [[medical weight loss]]		\| related = [[Semaglutide]], [[Wegovy]], [[Ozempic]], [[Liraglutide]], [[Saxenda]], [[GLP-1 receptor agonist]], [[medical weight loss]]
	}}		}}
	~~[[File:Tirzepatide structure.svg\|thumb\|right\|300px\|Chemical structure of [[tirzepatide]], the active ingredient in [[Zepbound]] and [[Mounjaro]].]]~~
	[[File:W8md weight loss sleep and medspa team.jpeg\|thumb\|right\|350px\|[[W8MD Weight Loss, Sleep and MedSpa]] provides physician-supervised [[medical weight loss]], [[GLP-1 weight loss]], [[sleep apnea]] care, and long-term [[weight maintenance]] support.]]		[[File:W8md weight loss sleep and medspa team.jpeg\|thumb\|right\|350px\|[[W8MD Weight Loss, Sleep and MedSpa]] provides physician-supervised [[medical weight loss]], [[GLP-1 weight loss]], [[sleep apnea]] care, and long-term [[weight maintenance]] support.]]
	[[File:Acanthosis-nigricans.jpeg\|Acanthosis nigricans\|350px\|right]]		[[File:Acanthosis-nigricans.jpeg\|Acanthosis nigricans\|350px\|right]]

Prab at 20:02, 24 June 2026

2026-06-24T20:02:47Z

Show changes

Prab: Removed redirect to Mounjaro

2023-02-23T23:57:39Z

Removed redirect to Mounjaro

← Older revision		Revision as of 23:57, 23 February 2023
Line 1:		Line 1:
	#~~REDIRECT~~ [[Mounjaro]]		Tirzepatide is a new medication that is currently being investigated for the treatment of obesity and type 2 diabetes. It is a once-weekly injection that works by targeting multiple hormones involved in glucose and energy regulation, leading to weight loss and improved blood sugar control.
			[[File:W8md weight loss sleep and medspa team.jpeg\|W8MD weight loss, sleep and medspa team\|thumb]]
			==Clinical trials==
			Clinical trials have shown that tirzepatide can result in significant weight loss in obese individuals with or without type 2 diabetes. In a phase 3 trial involving over 3,000 patients with type 2 diabetes, those who received the highest dose of tirzepatide (15 mg) lost an average of 12.4% of their body weight after one year, compared to 2.4% in the placebo group. The study also found that tirzepatide improved blood sugar control, reduced the need for diabetes medications, and lowered the risk of cardiovascular events.
			[[File:Weight-loss-success-stories.jpeg\|Weight loss success stories\|thumb]]
			==Weight loss results==
			Significant weight loss can occur as early as 28-weeks. Tirzepatide results suggest that it has one of the most promising results and is a great option for individuals struggling with obesity and type 2 diabetes. As with any medication, it is important to discuss the potential risks and benefits with a healthcare provider before starting treatment.
			==Diabetes results==
			When compared to other diabetes treatments, studies have shown that it can take 8 weeks to reach an A1C target of ≤7% and 12 weeks to reach an A1C ≤6.5% with Mounjaro.
			==FDA approval==
			This medication is FDA approved in the United States for diabetes but is also widely prescribed as off-label by doctors including W8MD doctors for weight loss. Results from a phase 3 trial showed that Mounjaro was highly effective in promoting [[weight loss]] in obese patients with an average BMI of 32-34. Patients on the highest dosage of Mounjaro (15 mg) lost an average of 12 pounds more than those on Ozempic, 29 pounds more than those on insulin degludec, and 27 pounds more than those on insulin glargine. These results demonstrate that Mounjaro has the potential to be a powerful tool in the treatment of obesity and related metabolic disorders.
			==Fast tracked for weight loss==
			Given one of the most promising and most effective weight loss results, the FDA is currently fast tracking this medication and is expected to FDA approved for weight loss sometime in 2023.
			==How can W8MD help?==
			W8MD Weight Loss, Sleep and MedSpa is a center that can prescribe medications for weight loss and diabetes management, including tirzepatide when it becomes available for clinical use. W8MD offers a comprehensive weight loss program that includes medical weight loss, nutritional counseling, and behavioral therapy to help individuals achieve long-term weight loss success and improve their overall health and wellbeing.
			==Need a doctor to prescribe?==
			Having been educated and experienced in Tirzepatide as well as any of the other weight loss medications, W8MD physicians can only guide you properly but also prescribe when appropriate. As one of the few weight loss doctors that accepts most insurances(with minimal program cost of just $50.00 above insurance), W8MD can help you.
			==Popularity==
			This drug, manufactured by Eli Lilly, has gained popularity for its weight loss benefits, and the hashtag #mounjaro has over 330 million.
			==Other services==
			In addition, W8MD also provides treatment for sleep disorders, which are often associated with obesity and type 2 diabetes. Sleep apnea, in particular, has been linked to weight gain and insulin resistance, which can worsen diabetes symptoms. W8MD offers sleep apnea treatment, including CPAP therapy and oral appliance therapy, to help individuals with sleep apnea improve their sleep and reduce the risk of obesity and diabetes complications.
			==Also see==
			* [[Mounjaro]]
			* [[Wegovy]] / [[Ozempic]]
			* [[Saxenda]] / [[Victoza]]
			* [[Weight loss medications]]
			{{nearby-locations}}

Prab: Redirected page to Mounjaro

2023-02-16T00:32:11Z

Redirected page to Mounjaro

New page

#REDIRECT [[Mounjaro]]

Tirzepatide - Revision history

Prab at 20:23, 24 June 2026

Prab at 20:02, 24 June 2026

Prab: Removed redirect to Mounjaro

Prab: Redirected page to Mounjaro